CANINE DIAGNOSTIC INNOVATIONS LTD

Company Registration Number:
12646135 (England and Wales)

Unaudited statutory accounts for the year ended 31 March 2023

Period of accounts

Start date: 1 April 2022

End date: 31 March 2023

CANINE DIAGNOSTIC INNOVATIONS LTD

Contents of the Financial Statements

for the Period Ended 31 March 2023

Directors report
Profit and loss
Balance sheet
Additional notes

CANINE DIAGNOSTIC INNOVATIONS LTD

Directors' report period ended 31 March 2023

The directors present their report with the financial statements of the company for the period ended 31 March 2023

Principal activities of the company

Canine Diagnostic Innovations Limited (“CDI Ltd”) is a wholly owned subsidiary of Medical Detection Dogs (the Charity). Therefore Medical Detection Dogs is the ultimate controlling company.The Charity has commissioned its Bio Detection Disease Research services via CDI Ltd during the year ended 31/03/2023. No external liabilities exist in CDI Ltd, and the entity is not ever expected to be loss making. CDI Ltd has a balance owed by Medical Detection Dogs (for Bio Research services provided) for £338,501. There is a corresponding amount owed by CDI Ltd to the charity related to the Charity having paid costs for Bio Research on CDI Ltd’s behalf.CDI Ltd has no employees, it subcontracts the research services it delivered during the year.CDI Ltd has supplied the charity with Bio Detection Disease Research services which it is eligible to claim research tax credits on. Research and Development (R&D) tax reliefs support UK companies working on innovative projects in science and technology. Companies are able to claim Corporation Tax relief if the project meets the standard definition of R&D. The work that qualifies for R&D tax relief must be part of a specific project to make an advance in science or technology.Research Tax Credit (RTC) income is recognised when the likelihood of a successful claim being made to HMRC on eligible expenditure is probable and can be measured reliably. The first claim will be made in respect of the CDI Ltd activities for the year to 31 March 2023. The claim for RTC has not been submitted to HMRC at the date of these financial statements, and therefore the criteria for recognising these funds have not been met.CDI Ltd was dormant in previous years, but has been active during the year ended 31 March 2023. The prior accounting period was for 9 months. This shorter accounting period was in place so that CDI Ltd could move to having a conterminous year end with its parent, Medical Detection Dogs.

Political and charitable donations

All profits generated by CDI Ltd are gifted to the charity.



Directors

The director shown below has held office during the whole of the period from
1 April 2022 to 31 March 2023

Claire Guest


The director shown below has held office during the period of
3 March 2023 to 31 March 2023

Clive Everest


Secretary James Yianni

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
19 October 2023

And signed on behalf of the board by:
Name: Claire Guest
Status: Director

CANINE DIAGNOSTIC INNOVATIONS LTD

Profit And Loss Account

for the Period Ended 31 March 2023

2023 9 months to 31 March 2022


£

£
Turnover: 338,501 0
Cost of sales: ( 338,501 ) 0
Gross profit(or loss): 0 0
Operating profit(or loss): 0 0
Profit(or loss) before tax: 0 0
Profit(or loss) for the financial year: 0 0

CANINE DIAGNOSTIC INNOVATIONS LTD

Balance sheet

As at 31 March 2023

Notes 2023 9 months to 31 March 2022


£

£
Called up share capital not paid: 1 1
Net current assets (liabilities):  
Total assets less current liabilities: 1 1
Total net assets (liabilities): 1 1
Capital and reserves
Called up share capital: 1 1
Total Shareholders' funds: 1 1

The notes form part of these financial statements

CANINE DIAGNOSTIC INNOVATIONS LTD

Balance sheet statements

For the year ending 31 March 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 19 October 2023
and signed on behalf of the board by:

Name: Claire Guest
Status: Director

The notes form part of these financial statements

CANINE DIAGNOSTIC INNOVATIONS LTD

Notes to the Financial Statements

for the Period Ended 31 March 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    All income is recognised once the company has entitlement to the funds, it is probable that income will be received, and the amount can be measured reliably. For the year ended 31 March 2023, turnover is represented by amounts owed by the company parent entity Medical Detection Dogs. All amounts owed are in respect of Bio Detection Disease Research services.Research Tax Credit (RTC) income is recognised when the likelihood of a successful claim being made to HMRC on eligible expenditure is probable and can be measured reliably. The first claim will be made in respect of the CDI Ltd activities for the year to 31 March 2023. The claim for RTC has not been submitted to HMRC at the date of these financial statements, and therefore the criteria for recognising these funds have not been met.

    Other accounting policies

    Taxation: Activities undertaken by the company are taxable, but no tax is due for the year. The company undertakes expenditure which is eligible under HMRC Research and Development (R&D) tax relief rules.Related Parties: CDI Ltd is 100% owned by the charity Medical Detection Dogs. It has a balance owed by Medical Detection Dogs (for Bio Research services provided) for £338,501. There is a corresponding amount owed by CDI Ltd to the charity related to the Charity having paid costs for Bio Research on CDI Ltd’s behalf. Intercompany balances with the same entity are netted off in these accounts.

CANINE DIAGNOSTIC INNOVATIONS LTD

Notes to the Financial Statements

for the Period Ended 31 March 2023

  • 2. Employees

    2023 9 months to 31 March 2022
    Average number of employees during the period 0 0